1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → HCID 178434469, compound
Reaction equation
[CH3:1][C:2]1[C:10]2[C:5](=[N:6][CH:7]=[C:8]([NH2:11])[CH:9]=2)[NH:4][N:3]=1.[F:12][C:13]1[C:21]([NH:22][S:23]([CH2:26][CH2:27][CH2:28][F:29])(=[O:25])=[O:24])=[CH:20][CH:19]=[C:18]([F:30])[C:14]=1[C:15](O)=[O:16].CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1>CN(C=O)C>[F:12][C:13]1[C:21]([NH:22][S:23]([CH2:26][CH2:27][CH2:28][F:29])(=[O:25])=[O:24])=[CH:20][CH:19]=[C:18]([F:30])[C:14]=1[C:15]([NH:11][C:8]1[CH:9]=[C:10]2[C:2]([CH3:1])=[N:3][NH:4][C:5]2=[N:6][CH:7]=1)=[O:16]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
3-Methyl-1H-pyrazolo[3,4-b]pyridin-5-amine (0.100 g, 0.675 mmol, Example 4, Step B), 2,6-difluoro-3-(3-fluoropropylsulfonamido)benzoic acid (0.211 g, 0.709 mmol), EDCI (0.136 g, 0.709 mmol) and HOBt (0.091 g, 0.675 mmol) were dissolved in DMF (1.9 mL) and stirred at room temperature for 16 hours. The reaction mixture was purified by reverse phase HPLC to give 2,6-difluoro-3-(3-fluoropropylsulfonamido)-N-(3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)benzamide (0.085 g, 29%) as a solid. 1H NMR (400 MHz, d6-DMSO) δ 13.22 (s, 1H), 11.05 (s, 1H), 9.93 (br s, 1H), 8.60-8.59 (m, 1H), 8.55-8.54 (m, 1H), 7.59-7.53 (m, 1H), 7.30-7.25 (m, 1H), 4.62 (t, 1H), 4.50 (t, 1H), 3.26-3.23 (m, 2H), 2.20-2.07 (m, 2H); m/z (ES-MS) 428.1 (100.0%) [M+1].
Workup
- customThe reaction mixture was purified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-8e90b7c98f97430ab6be0662da1b8114
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08394795B2
Reaction notes
Loading…